Signal detection and analysis of adverse event of Trastuzumab Deruxtecan based on FARES database open vigil specially in treating her 2 positive breast cancer

1. Introduction 1.1 Background of HER2+ Breast Cancer 1.2 Overview of Trastuzumab Deruxtecan 1.3 Importance of Signal Detection 2. Trastuzumab Deruxtecan 2.1 Mechanism of Action 2.2 Clinical Efficacy in HER2+ Breast Cancer 2.3 Known Adverse Events 3. Adverse Event Reporting 3.1 Role of FARES Database 3.2 Open Vigil in Pharmacovigilance 3.3 Data Collection Methods 4. Signal Detection Methods 4.1 Statistical Techniques 4.2 Qualitative Analysis 4.3 Integration of Data Sources 5. Analysis of FARES Data 5.1 Data Extraction Process 5.2 Signal Detection Results 5.3 Interpretation of Findings 6. Case Studies 6.1 Case Study: Severe Adverse Event 6.2 Case Study: Rare Adverse Event 6.3 Comparative Analysis with Other Drugs 7. Implications for Clinical Practice 7.1 Risk Management Strategies 7.2 Recommendations for Healthcare Providers 7.3 Patient Communication Strategies 8. Conclusion 8.1 Summary of Findings 8.2 Limitations of the Study 8.3 Future Research Directions